TrialThe Lancet. Global health2025

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Eve Nakabembe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.